Virax Biolabs’ proprietary in-development diagnostic technology for post-acute infection syndromes (“PAIS”), such as Long COVID, positions the Company for an important data year ahead, following a series of recent clinical and operational milestones over the past 12 months.
Myalgic encephalomyelitis (ME/CFS), also known as chronic fatigue syndrome, is a complex condition characterized by post-exertional fatigue and a range of neuroimmune symptoms. It is one of several debilitating conditions that fall under the diagnostic umbrella of post-acute infection syndrome (PAIS) due to its association with an incomplete recovery from viral disease. ME/CFS often […]
Diagnosing chronic, post-acute inflammatory conditions – like Long COVID – remains a persistent challenge for researchers and healthcare professionals alike12. The variable presentation of symptoms – along with the allusivity of an exact cause – make these conditions difficult to pin down in the clinic. Current diagnostic approaches rely on highly speculative patient questionnaires; […]
